UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000063372
Receipt number R000072356
Scientific Title Development and Evaluation of the Medium-Term Effects of an Augmented Reality-Based Nasogastric Tube Feeding Training Program
Date of disclosure of the study information 2026/10/23
Last modified on 2026/10/21 16:03:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Augmented Reality Smart Glasses-Based Nasogastric Tube Feeding Training for Nursing Students

Acronym

AR Nasogastric Tube Feeding Study

Scientific Title

Development and Evaluation of the Medium-Term Effects of an Augmented Reality-Based Nasogastric Tube Feeding Training Program

Scientific Title:Acronym

AR Nasogastric Tube Feeding Study

Region

Japan


Condition

Condition

Not applicable (Nursing education)

Classification by specialty

Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To develop an augmented reality (AR) smart glasses-based training program for nasogastric tube feeding catheter insertion in undergraduate nursing education and to investigate its medium-term retention effects.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Procedural accuracy score assessed using an OSCE-style checklist at baseline, immediately after training, and 4 weeks after training. Changes over time will be compared between the intervention and control groups.

Key secondary outcomes

1) Knowledge score (before, immediately after, and 4 weeks after training); 2) cognitive workload assessed using the Japanese NASA-TLX (immediately after training); 3) procedure time (before, immediately after, and 4 weeks after training); 4) occurrence of critical errors (before, immediately after, and 4 weeks after training); and 5) group interviews regarding strengths, points for improvement, and perceived changes in skills and knowledge (immediately after, and 4 weeks after training).


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Maneuver

Interventions/Control_1

After completing baseline assessment, participants will undertake 20 minutes of self-practice for nasogastric tube feeding while referring to images, videos, text, and audio displayed on augmented reality smart glasses. Skills, knowledge, and related outcomes will be assessed immediately after training and 4 weeks later.

Interventions/Control_2

After completing baseline assessment, participants will undertake 20 minutes of self-practice for nasogastric tube feeding using a booklet containing the same images and explanatory text as the smart-glasses content. Skills, knowledge, and related outcomes will be assessed immediately after training and 4 weeks later. Participants who wish to use the smart glasses will be offered an opportunity after study completion.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Fourth-year undergraduate nursing students who provide written informed consent to participate.

Key exclusion criteria

Individuals with a history of severe physical discomfort caused by augmented reality devices, such as motion sickness or severe eye strain.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Kurumi
Middle name
Last name Asaumi

Organization

Tokyo University of Technology

Division name

Department of Nursing, School of Health Sciences

Zip code

144-8535

Address

5-23-22,Nishikamata,Ota-ku,Tokyo

TEL

03-6424-2173

Email

asaumikrm@stf.teu.ac.jp


Public contact

Name of contact person

1st name Kurumi
Middle name
Last name Asaumi

Organization

Tokyo University of Technology

Division name

Department of Nursing, School of Health Sciences

Zip code

144-8535

Address

5-23-22,Nishikamata,Ota-ku,Tokyo

TEL

0364242173

Homepage URL


Email

asaumikrm@stf.teu.ac.jp


Sponsor or person

Institute

Tokyo University of Technology

Institute

Department

Personal name

Kurumi Asaumi


Funding Source

Organization

Tokyo University of Technology

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee, Tokyo University of Technology

Address

1404-1 Katakura-machi, Hachioji-shi, Tokyo

Tel

042-637-1163

Email

jm-rsc@stf.teu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京工科大学(東京都)


Other administrative information

Date of disclosure of the study information

2026 Year 10 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 10 Month 07 Day

Date of IRB

2026 Year 10 Month 07 Day

Anticipated trial start date

2026 Year 11 Month 02 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 10 Month 22 Day

Last modified on

2026 Year 10 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072356